Moleculin Biotech to Report Financial Results for Q3 2024 Houston, TX–(November 5, 2024)–Moleculin Biotech, Inc. (NASDAQ: MBRX) announced in an 8-K filing today that it will disclose its financial results for the quarter ending September 3
8 Nov 10:32 · 1 article